Takeda To Offer Researchers Quality-Work Compensation
This article was originally published in PharmAsia News
Executive SummaryTakeda Pharmaceuticals, facing patent expirations on two of its bestselling drugs, plans to revamp its research-and-development policy to provide quality bonuses to scientists. President Yasuchika Hasegawa said Takeda has been putting too much emphasis on research quantity and speed and expects to change mindsets by providing quality-based compensation. He said rushing research is not helpful to the company's need to introduce medicines. (Click here for more
You may also be interested in...
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.